Maybe, but the same scenario you described happened to a post of mine on another board, while on other boards, other posts made by me today have taken.
Any conspiracy theorists out there???
I'm fearful of any management that manages to "support" its stock.
If the business is managed well, the share price will perform accordingly (over the real definition of "long run").
vincent, you are confused.
First off, KMI et al are HUGE and IMO retail investor actions do not have much affect on the share price.
"Cramer has single handedly destroyed more individual's wealth...blah, blah..."
Wrong. Each individual is RESPONSIBLE for their own actions.
If you can't stand the heat, get out of the kitchen!
P.S. It's time you take responsibility for your actions (what a novel idea!)
Wow, r55keeler, apparently you know something that KMI management is unaware of....
How does your track record of running a business compare to Rich Kinder's record???
Aug 8 close: 36.12
Sep 3 approx close 39.57
Oh the horror!
Yeah something is fishy here, but it's not what you "thought"; what is fishy is the title of your post "Broken Stock".
Or.....it could simply be many agree with the substance of that particular post.
I imagine most Americans would like to see those who are responsible for various "errors of judgement" to be culpable, and not just the company itself.
"If you own the stock why dont you know when ex div date is. I never owned a stock without knowing that. People who dont know these simple things should not be in the equities market period."
Well your sentiment seems a tad harsh. Had you written about not knowing what "ex-div" is, I might be in agreement. I have NO idea of the ex dates of the numerous equity positions I own; I'm not clear how knowing an ex date is beneficial--especially for investors (read long term holders).
The "news" was pretty much a forgone conclusion. Once the vote was confirmed, as others have noted, for the short term, it's sell on the news. IMO, just noise--heck, the shares are still in the 40's (for now).
You must be relatively new investing.
Back in the day, before option grants became so prevalent, once in a while one would witness insider buying or selling. Fast forward to today and you don't see many market buys by insiders, but the selling, not surprisingly periodically continues. No surprise re no insider buying; why would an insider buy if they don't have to risk their own capital and just exercise options if profitable to do so and then sell the shares?
Bottom line, IMO, it would be foolish to think yesterday's selling by a insider meant anything at all with the exception the insider wanted to monetize some of his exposure to JNJ.
Where does TRC hold its annual meeting? Not sure about the most recent one, but in the past: Newport Beach, Irvine...
I do see that the 9/25 quarterly BOD meeting will be held in the Community Meeting Room at the new City of Tehachapi Police Station!
For an excellent overview of KMI, check out the Morningstar piece below KMI YahooFinance quote dated 9/26.
(tiglet has already mentioned this, but it may have been lost on those who avoid political rants on stock message boards.)
“Wiggles, start by looking in the mirror and saying you only have yourself to blame. It will be a start towards your salvation. To state that Kaul's management of FBIX didn't beat IBB is flat out wrong.” (I only made that statement at the onset and rectified this; why do you continue to harp on this? (to distract one from the truth?)
Isn’t it a bit childish to manipulate another poster’s moniker?
You seem to have a fascination with mirrors.
“blame” for what?
I am not in need of “salvation”.
My original comment was, now I’m paraphrasing, while Kaul has done well, I don’t think he should be deified by its shareholders given how FBIOX has performed compared to IBB.
Yes, I originally stated that IBB had outperformed FBIOX and I was WRONG. I was alerted by you that YahooF’s chart only showed price movement and not total return.
To rectify my error, in a subsequent post, I posted TOTAL RETURN figures for both FBIOX & IBB, sourced from a legitimate provider, a Bloomberg terminal. BUT…you didn’t like the numbers and “gently” suggested I was clueless.
Shockingly, you demonstrated that you were incapable of calculating percentage changes:
“59 to 226 equaled 383%” WRONG; while 226 is 3.83 times greater than 59, a move from 59 to 226 represents a 283 PERCENT CHANGE in price. How about a “quadruple equals 400%”? (it’s 300%).
Since you didn’t like the Bloomberg numbers, I have sought out the gold standard: the FBIOX prospectus.
There's my hook! To be continued on my next post...
The prospectus shows annualized TOTAL RETURN figures for both FBIOX, S&P 500 (IMO rather meaningless) and the index that the powers that be at Fido determined to be a suitable benchmark: MSCI US IMI Biotechnology 25-50 Index (which I will refer to as “MSCI”).
All for periods ending 12/31/13. Let’s review what is found in the PROSPECTUS:
FBIOX annualized returns first, then MSCI’s (and for fun! lastly, IBB’s)
1 Y: 65.66% 66.53% 65.54%
5 Y: 26.98% 24.85% 26.43%
10 Y:14.25% 15.13% 12.33%
Funny thing: when I ran the comp function on Bloomberg, I got the SAME TOTAL RETURN figures! In other words, not only am I capable of using a Bloomberg, but Bloomberg does provide ACCURATE calculations. Bloombergs are on just about EVERY trading desk for a very good reason.
Bottom line: The only “point” I was trying to convey was, IMO some posters were a tad enthusiastic re Kaul’s performance and I attempted to demonstrate why I felt this way.
I was incorrect when I Initially stated that IBB had outperformed FBIOX over some of the time frames cited and I provided accurate TOTAL RETURN info from a Bloomberg.
I believe citing figures from FBIOX’s prospectus will satisfy my statement re Kaul.
As noted above, FBIOX has not beaten its chosen benchmark by a wide margin.
One big difference between us: I have acknowledged an error, whereas you have been radio silent about your % calculation errors. I hope I have taught you something.
P.S. I am not long IBB.
P.P.S. What really matters is that we both have biotech exposure and lately that has been a good thing.
That's an apt description of YOU!
P.S. Why don't you post on the DMND board? Months back, with DMND's share price much lower than it is today, you incessantly posted silly, foolish posts and now, radio silence.
Don't you bore yourself with the same schtick???
"Wall Street owes billions to the people in TRC's area for 3 decades of
stock-manipulation that severely #$%$ their economic development.
Many might become TRC-holders if its price & policies were rational."
I'm not clear how the above relates to your prior post suggesting TRC invest in equities.
If you are superstitious:
"Maybe it's time to ditch your newly minted moniker and go back to the silver one you created two weeks ago."
vape has gone in one direction (DOWN) since you started you latest "identity" LOL!!!
While I sold approx. 20% of my biotech position in January, after being long 10+ years, I pretty much concur with your "never" sell time frame. Of course, one should consider why they invested in the sector in the first place, and unless their circumstances have changed, I say buy and hold. Some day, when I'm looking for more income, I may sell some more, but for now, I'm looking for appreciation and I think this sector is a good place to invest SOME funds, but I wouldn't want to have biotech overweighted in my portfolio.
As you noted, a possible time to consider selling is when the portfolio manager departs.
Re "...the best biotech investor of our time...", while Kaul has done very well, you (and others) may be surprised how FBIOX has fared compared to IBB, iShares Biotech ETF.
IBB has outperformed FBIOX during the past
while FBIOX has outperformed IBB during the past 3 and 1 month periods.
Simply pull up the FBIOX chart and compare with IBB, using the above time frames.
YOUR post was "all over the place".
What's up with the "you would also have to add other factors to your cost basis like broker's costs when buying or selling, costs for phone calls and equipment, check writing costs, computer costs including depreciation..." You're just being silly.
Since a subscription to a Bloomberg terminal is quite steep, I am fortunate that my employer pays for it; my employer is a Broker Dealer.
Forget about everything we have "discussed".
What matters is that you have NO CLUE how to calculate a percentage move.
"If you insist on deducting your cost basis to show a different number that's up to your discretion..."
Not my discretion; it is the how it is done!!!
".. if a share quadruples in price then it went up 400%.
That is INCORRECT.
If a share quadruples in price, your gain would be 300%
"That is the way all analysts judge the performance of equities."
I surely hope not LOL!!!
FBIOX went from $59 to $226 including dividends over the past five years for an increase of 383%
"Again", that is incorrect. The price increased 283%
Obviously you do not accept my math, so let's go to the internet!
I searched "how to calculate percentage gain between two numbers" on Google, and I clicked on the first hit and it yielded (pun) the following:
To calculate the percentage increase:
First: work out the difference (increase) between the two numbers you are comparing.
Increase = New Number - Original Number
Then: divide the increase by the original number and multiply the answer by 100.
% increase = Increase ÷ Original Number × 100.
Let's use the numbers you cited: 59 start 226 end
226 - 59 = 167
167 / 59 = 2.83 2.83 x 100 = 283%
You are welcome!
Not sure if being cheaper is better or not, but thought longs may be interested.
To read the Bloomberg article, check out today's 7:03 AM Bloomberg article "Whole Foods Plays Bargain Grocer in Manhattan"